We use cellcept often and some centers prefer Myfortic. A common reason to switch usually is GI side effects more noted in cellcept.
Is there any difference? otherwise in outcomes of both patients.A retrospective analysis was done of over 45,000 patients from the UNOS database. They measured graft failure, death with graft, acute rejection, NODAT, and renal function.
To answer this question, a nice paper in Transplantation talks about this. A large retrospective trial of 48,000 patients using the UNOS database was done. End points were graft failure, death with functioning graft, NODAT, acute rejection, and renal function. around 10% were on myfortic and remaining on cellcept.
Propensity score-adjusted regression analysis showed that patients who received myfortic were at increased risk of biopsy proven acute rejection. The adjusted biopsy proven acute rejection rate difference at 3 years post transplant was less than 2% statistically significant due to large number of patients. There was no difference in graft survival, NODAT, renal function and other measures.
Interesting to note this difference. Overall, in terms of graft survival , this RETROSPECTIVE LARGE study showed no major difference. The authors think that due to the large numbers, this difference was less meaningful.
http://www.ncbi.nlm.nih.gov/pubmed/20445488
Subscribe to:
Post Comments (Atom)
All Posts
-
▼
2010
(461)
-
▼
May
(48)
- Paricalcitol and CNI injury?
- Nephrology Crosswords
- TOPIC DISCUSSION: Shock wave lithotripsy for kidne...
- Role Playing in Transplant Teaching
- Role Playing in Transplant Teaching
- The SPLEEN in ANTIBODY MEDIATED REJECTION
- IN THE NEWS ---> FONT TRIAL
- IN THE NEWS ---> MCD vs FSGS
- Topic Discussion: Aldosterone
- Kidney Autotransplantation
- Risk of PTLD post transplant?
- The Online Transplant Center: Risk of PTLD post tr...
- Size and the Kidney from NephrologyWorld
- TOPIC DISCUSSION: Hyperammonemia and the Nephrologist
- Cellcept vs Myfortic? any difference!!
- EVEROLIMUS FOR KIDNEY TRANSPLANTS
- CLINICAL CASE 14 , ANSWER and SUMMARY
- TOPIC DISCUSSION: low K and low Mg??
- IN THE NEWS- VEGF and renal disease
- The effect of Mycophenolic Acid (MPA) on donor spe...
- The Extra Degrees!!!
- CONSULT ROUNDS: CONTRAST and ESRD/CKD
- TOPIC DISCUSSION: PHEOCHROMOCYTOMA
- Rituximab for recurrent idiopathic Membranous GN
- CD4 T cell lymphopenia is bad!
- Nephrology Crosswords
- CONSULT ROUNDS: Peritonitis
- Drug coverage for transplant from Nephrologyworld ...
- Topic Discussion: ANCA Disease
- IN THE NEWS- AGE and NEPHROSCLEROSIS
- CMV in organ transplantation
- CLINICAL CASE 13
- IN THE NEWS: encapsulating peritoneal sclerosis
- Check out the Latest from the world of Pediatrics
- TOPIC DISCUSSION: Interferon and the kidney
- New-Onset Diabetes Linked to Post-Transplant Hypom...
- New News on Belatacept
- Paired Donor Exchange Programs
- Bortezemib and highly sensitized patients
- H1N1 and Transplantation
- Complement activation and Antibody mediated rejection
- ATC Conference highlights 2010
- CONSULT ROUNDS: Distal RTA
- Are Generics trustworthy?
- TOPIC DISCUSSION: METHANOL and TOXIC EFFECTS
- New-Onset Diabetes Linked to Post-Transplant Hypom...
- American Transplant Congress from ECU
- TOPIC DISCUSSION: Hypokalemia causing Hyponatremia
-
▼
May
(48)
Not statistically different unless you were forced to switch and the creatnine numbers jump. Myfortic needs further study.
ReplyDeleteI agree, every since my child was force to switch he has had sever weight loss- no appitiete-real bad gas and more!
ReplyDelete